| ACT ENALAPRIL (2 MG)Teva Canada Limited · Status since Aug 2017 | 02291878 | Marketed | Teva Canada Limited | Aug 2017 |
| ACT ENALAPRIL (4 MG)Teva Canada Limited · Status since Aug 2017 | 02291886 | Marketed | Teva Canada Limited | Aug 2017 |
| ACT ENALAPRIL (8 MG)Teva Canada Limited · Status since Aug 2017 | 02291894 | Marketed | Teva Canada Limited | Aug 2017 |
| ACT ENALAPRIL (16 MG)Teva Canada Limited · Status since Aug 2017 | 02291908 | Marketed | Teva Canada Limited | Aug 2017 |
| ENALAPRIL (2 MG)Sivem Pharmaceuticals Ulc · Status since Oct 2018 | 02442957 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2018 |
| ENALAPRIL (4 MG)Sivem Pharmaceuticals Ulc · Status since Oct 2018 | 02442965 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2018 |
| ENALAPRIL (8 MG)Sivem Pharmaceuticals Ulc · Status since Oct 2018 | 02442973 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2018 |
| ENALAPRIL (16 MG)Sivem Pharmaceuticals Ulc · Status since Oct 2018 | 02442981 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2018 |
| TARO-ENALAPRIL (2 MG)Sun Pharma Canada Inc. · Status since Feb 2022 | 02352230 | Marketed | Sun Pharma Canada Inc. | Feb 2022 |
| TARO-ENALAPRIL (4 MG)Sun Pharma Canada Inc. · Status since Feb 2022 | 02352249 | Marketed | Sun Pharma Canada Inc. | Feb 2022 |
| TARO-ENALAPRIL (8 MG)Sun Pharma Canada Inc. · Status since Feb 2022 | 02352257 | Marketed | Sun Pharma Canada Inc. | Feb 2022 |
| TARO-ENALAPRIL (16 MG)Sun Pharma Canada Inc. · Status since Feb 2022 | 02352265 | Marketed | Sun Pharma Canada Inc. | Feb 2022 |
| VASERETIC (8 MG)Organon Canada Inc. · Status since Feb 2022 | 00657298 | Marketed | Organon Canada Inc. | Feb 2022 |
| VASOTEC (8 MG)Organon Canada Inc. · Status since Apr 2022 | 00670901 | Marketed | Organon Canada Inc. | Apr 2022 |
| VASOTEC (16 MG)Organon Canada Inc. · Status since Jun 2022 | 00670928 | Marketed | Organon Canada Inc. | Jun 2022 |
| VASOTEC (4 MG)Organon Canada Inc. · Status since Apr 2022 | 00708879 | Marketed | Organon Canada Inc. | Apr 2022 |
| DOM-ENALAPRIL (2.0 MG)Dominion Pharmacal · Status since May 2017 | 02308258 | Cancelled Pre Market | Dominion Pharmacal | May 2017 |
| DOM-ENALAPRIL (4 MG)Dominion Pharmacal · Status since May 2017 | 02308266 | Cancelled Pre Market | Dominion Pharmacal | May 2017 |
| DOM-ENALAPRIL (8 MG)Dominion Pharmacal · Status since May 2017 | 02308274 | Cancelled Pre Market | Dominion Pharmacal | May 2017 |
| DOM-ENALAPRIL (16 MG)Dominion Pharmacal · Status since May 2017 | 02308282 | Cancelled Pre Market | Dominion Pharmacal | May 2017 |
| ENALAPRIL (2.0 MG)Cobalt Pharmaceuticals Incorporated · Status since Sep 2017 | 02343460 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| ENALAPRIL (4.0 MG)Cobalt Pharmaceuticals Incorporated · Status since Sep 2017 | 02343479 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| ENALAPRIL (8.0 MG)Cobalt Pharmaceuticals Incorporated · Status since Sep 2017 | 02343487 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| ENALAPRIL (16 MG)Cobalt Pharmaceuticals Incorporated · Status since Sep 2017 | 02343495 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| ENALAPRIL (2 MG)Frosst A Division Of Merck Canada Inc · Status since May 2016 | 02398486 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| ENALAPRIL (4 MG)Frosst A Division Of Merck Canada Inc · Status since May 2016 | 02398494 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| ENALAPRIL (8 MG)Frosst A Division Of Merck Canada Inc · Status since May 2016 | 02398508 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| ENALAPRIL (16 MG)Frosst A Division Of Merck Canada Inc · Status since May 2016 | 02398516 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| ENALAPRIL/HCTZ (8 MG)Frosst A Division Of Merck Canada Inc · Status since May 2016 | 02398478 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| MYLAN-ENALAPRIL (2 MG)Mylan Pharmaceuticals Ulc · Status since Jan 2020 | 02300036 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jan 2020 |
| MYLAN-ENALAPRIL (4 MG)Mylan Pharmaceuticals Ulc · Status since Jan 2020 | 02300044 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jan 2020 |
| MYLAN-ENALAPRIL (8 MG)Mylan Pharmaceuticals Ulc · Status since Jan 2020 | 02300052 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jan 2020 |
| MYLAN-ENALAPRIL (16 MG)Mylan Pharmaceuticals Ulc · Status since Jan 2020 | 02300060 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jan 2020 |
| NTP-ENALAPRIL (2 MG)Teva Canada Limited · Status since Aug 2015 | 02381605 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-ENALAPRIL (4 MG)Teva Canada Limited · Status since Aug 2015 | 02381613 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-ENALAPRIL (8 MG)Teva Canada Limited · Status since Aug 2015 | 02381621 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-ENALAPRIL (16 MG)Teva Canada Limited · Status since Aug 2015 | 02381648 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-ENALAPRIL (32 MG)Teva Canada Limited · Status since Aug 2015 | 02381656 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| PMS-ENALAPRIL (2.0 MG)Pharmascience Inc. · Status since Sep 2015 | 02300079 | Cancelled Post Market | Pharmascience Inc. | Sep 2015 |
| PMS-ENALAPRIL (4 MG)Pharmascience Inc. · Status since Dec 2016 | 02300087 | Cancelled Post Market | Pharmascience Inc. | Dec 2016 |
| PMS-ENALAPRIL (8 MG)Pharmascience Inc. · Status since Sep 2015 | 02300095 | Cancelled Post Market | Pharmascience Inc. | Sep 2015 |
| PMS-ENALAPRIL (16 MG)Pharmascience Inc. · Status since Feb 2016 | 02300109 | Cancelled Post Market | Pharmascience Inc. | Feb 2016 |
| RATIO-ENALAPRIL (2.0 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Sep 2014 | 02299984 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Sep 2014 |
| RATIO-ENALAPRIL (4.0 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Sep 2014 | 02299992 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Sep 2014 |
| RATIO-ENALAPRIL (8.0 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Sep 2014 | 02300001 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Sep 2014 |
| RATIO-ENALAPRIL (16 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Sep 2014 | 02300028 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Sep 2014 |
| RIVA-ENALAPRIL (2 MG)Laboratoire Riva Inc. · Status since Jun 2021 | 02300796 | Cancelled Post Market | Laboratoire Riva Inc. | Jun 2021 |
| RIVA-ENALAPRIL (4 MG)Laboratoire Riva Inc. · Status since Jun 2021 | 02300818 | Cancelled Post Market | Laboratoire Riva Inc. | Jun 2021 |
| RIVA-ENALAPRIL (8 MG)Laboratoire Riva Inc. · Status since Jun 2021 | 02300826 | Cancelled Post Market | Laboratoire Riva Inc. | Jun 2021 |
| RIVA-ENALAPRIL (16 MG)Laboratoire Riva Inc. · Status since Jul 2021 | 02300834 | Cancelled Post Market | Laboratoire Riva Inc. | Jul 2021 |
| SANDOZ ENALAPRIL (2 MG)Sandoz Canada Inc. · Status since Jul 2026 | 02299933 | Cancelled Post Market | Sandoz Canada Inc. | Jul 2026 |
| SANDOZ ENALAPRIL (4 MG)Sandoz Canada Inc. · Status since Jul 2026 | 02299941 | Cancelled Post Market | Sandoz Canada Inc. | Jul 2026 |
| SANDOZ ENALAPRIL (8 MG)Sandoz Canada Inc. · Status since Jul 2026 | 02299968 | Cancelled Post Market | Sandoz Canada Inc. | Jul 2026 |
| SANDOZ ENALAPRIL (16 MG)Sandoz Canada Inc. · Status since Jul 2026 | 02299976 | Cancelled Post Market | Sandoz Canada Inc. | Jul 2026 |
| SIG-ENALAPRIL (2.0 MG)Sigmacon Lifesciences Inc · Status since Aug 2015 | 02323478 | Cancelled Post Market | Sigmacon Lifesciences Inc | Aug 2015 |
| SIG-ENALAPRIL (4 MG)Sigmacon Lifesciences Inc · Status since Aug 2015 | 02323486 | Cancelled Post Market | Sigmacon Lifesciences Inc | Aug 2015 |
| SIG-ENALAPRIL (8.0 MG)Sigmacon Lifesciences Inc · Status since Aug 2015 | 02323494 | Cancelled Post Market | Sigmacon Lifesciences Inc | Aug 2015 |
| SIG-ENALAPRIL (16 MG)Sigmacon Lifesciences Inc · Status since Aug 2015 | 02323508 | Cancelled Post Market | Sigmacon Lifesciences Inc | Aug 2015 |
| TARO-ENALAPRIL (2.0 MG)Taro Pharmaceuticals Inc · Status since Jan 2022 | 02300117 | Cancelled Post Market | Taro Pharmaceuticals Inc | Jan 2022 |
| TARO-ENALAPRIL (4 MG)Taro Pharmaceuticals Inc · Status since Jan 2022 | 02300125 | Cancelled Post Market | Taro Pharmaceuticals Inc | Jan 2022 |
| TARO-ENALAPRIL (8 MG)Taro Pharmaceuticals Inc · Status since Jan 2022 | 02300133 | Cancelled Post Market | Taro Pharmaceuticals Inc | Jan 2022 |
| TARO-ENALAPRIL (16 MG)Taro Pharmaceuticals Inc · Status since Jan 2022 | 02300141 | Cancelled Post Market | Taro Pharmaceuticals Inc | Jan 2022 |
| TEVA-ENALAPRIL (4 MG)Teva Canada Limited · Status since Aug 2019 | 02233005 | Cancelled Post Market | Teva Canada Limited | Aug 2019 |
| TEVA-ENALAPRIL (8 MG)Teva Canada Limited · Status since Aug 2019 | 02233006 | Cancelled Post Market | Teva Canada Limited | Aug 2019 |
| TEVA-ENALAPRIL (16 MG)Teva Canada Limited · Status since Aug 2019 | 02233007 | Cancelled Post Market | Teva Canada Limited | Aug 2019 |
| TEVA-ENALAPRIL (2.0 MG)Teva Canada Limited · Status since May 2018 | 02300680 | Cancelled Post Market | Teva Canada Limited | May 2018 |
| TEVA-ENALAPRIL (32 MG)Teva Canada Limited · Status since May 2018 | 02330601 | Cancelled Post Market | Teva Canada Limited | May 2018 |
| TEVA-ENALAPRIL/HCTZ (4 MG)Teva Canada Limited · Status since Jun 2018 | 02300222 | Cancelled Post Market | Teva Canada Limited | Jun 2018 |
| TEVA-ENALAPRIL/HCTZ (8 MG)Teva Canada Limited · Status since Jun 2018 | 02300230 | Cancelled Post Market | Teva Canada Limited | Jun 2018 |
| VASERETIC (4 MG)Merck Canada Inc · Status since May 2008 | 02242826 | Cancelled Post Market | Merck Canada Inc | May 2008 |
| VASOTEC (2 MG)Merck Canada Inc · Status since Dec 2016 | 00851795 | Cancelled Post Market | Merck Canada Inc | Dec 2016 |